Menù dei Marcatori

Ipertesto Neoplasie

 

LINKS

 

 

Scheda a cura di Marco Chilosi  (GYM)      

 

CLASSIFICAZIONE WHO             Classificazione "istogenetica" di                  

                                                            Muller-Hermelink

 

 

 

Tipo AB       Timoma Misto

 

Tipo A                                  Midollare

Tipo AB                               Misto

Tipo B1                                Predominant. corticale / organoide

Tipo B2                                Corticale

Tipo B3                                Carcinoma timico ben differenziato

Tipo C                                  Carcinoma timico

 

Nel timoma AB coesistono aspetti di timoma di tipo A e di tipo B. 

Le aree "corticali" sono formate da aggregati di cellule epiteliali a nucleo vescicoloso associate in varia misura a timociti CD1a +, TdT+. 

Le aree "midollari" sono costituite da cellule fusate e scarsi timociti.  L'espressione di citocheratine ad alto peso (CK 34bE12) è elevata in tutto il tumore. La CK14 è espressa in modo variabile da zona a zona. 

 

EE

 

 

 

EE1 00-858.JPG (293183 byte)    EE2 00-858.JPG (290822 byte)

     

 

CK 34bE12

 

CK903 A00-858.JPG (275341 byte)     CK903 00-858.JPG (345130 byte)

 

 

   

 

ricca componente di timociti CD1a +

CD1 00-858.JPG (314058 byte)

 

Nella maggior parte dei timomi AB le cellule epiteliali esprimono in modo anomalo antigene CD20. Questa anomala espressione è molto specifica ed è utilizzata per la caratterizzazione di queste forme.

 

CD20

CD20 00-858.JPG (350088 byte)     CD20D 00-858.JPG (337785 byte)

 

 

Am J Surg Pathol 1992 Oct;16(10):988-97
Neoplastic epithelial cells in a subset of human thymomas express the B cell-associated CD20 antigen.
Chilosi M, Castelli P, Martignoni G, Pizzolo G, Montresor E, Facchetti F, Truini M, Mombello A, Lestani M, Scarpa A, et al.
Istituto di Anatomia Patologica, Universita di Verona, Italy.
   
A series of 36 human thymomas have been immunohistochemically analyzed using a panel of antibodies recognizing B-cell markers including CD20. Most thymomas exhibiting the cortical pattern, according to the criteria of Marino and Muller-Hermelink, were characterized by areas of medullary differentiation containing variable numbers of CD20+ B lymphocytes, thus mimicking the medulla of normal thymus. On the other hand, B cells were absent or rare in thymomas recognized as mixed using the same morphological criteria. Surprisingly, we observed in most mixed thymomas variable numbers of CD20+ spindle cells, characterized by long slender processes. Using double-marker analysis we could demonstrate the epithelial nature of these cells (expression of keratin and lack of lymphoid and B-cell-related markers). The immunoreactivity of thymoma epithelial cells with L26, an antibody widely used in the characterization of B-cell lymphomas, can represent a drawback of practical relevance in the differential diagnosis of mediastinal tumors.


Am J Surg Pathol 2001 Jan;25(1):111-20

Spindle cell and mixed spindle/lymphocytic thymomas: an integrated clinicopathologic and immunohistochemical study of 81 cases.
Pan CC, Chen WY, Chiang H.
Department of Pathology, National Yang-Ming University and Veterans General Hospital-Taipei, Taiwan. ccpan@vghtpe.gov.tw
    Forty-three cases of spindle cell thymoma (medullary, WHO type A) and 38 cases of mixed spindle/lymphocytic thymoma (WHO type AB) were studied for their clinicopathologic and immunohistochemical characteristics. Three histologic patterns of spindle cell thymoma were observed: short-spindled (57%), long-spindled (31%), and micronodular (12%). The short-spindled variant was composed of oval to short spindle cells commonly arranged in a hemangiopericytic or microcystic pattern. The long-spindled variant chiefly consisted of fibroblast-like epithelial cells mimicking fibrohistiocytic neoplasms. The micronodular variant was characterized by small nests of short spindle cells dispersed among a lymphoid stroma with frequent germinal centers. All kinds of spindle cell could be admixed with lymphocyte-rich "cortex"-like areas to constitute mixed spindle/lymphocytic thymomas. Immunohistochemically, the epithelial cells in up to 70% of the short-spindled and long-spindled variants of spindle cell thymoma and 90% of mixed spindle/lymphocytic thymomas were positive for CD20, whereas the epithelial cells in all micronodular spindle cell thymomas were negative. All of the spindle cell thymomas and most of the mixed spindle/lymphocytic thymomas in this study were found in stages I and II. Follow up of the patients did not disclose relapse or mortality directly resulting from the tumors. However, the prognosis of stage I and II spindle cell and mixed spindle/lymphocytic thymomas did not significantly differ from those of stage I and II thymomas of other types by a stage-matched survival analysis. Our data showed that spindle cell and mixed spindle/lymphocytic thymomas are distinctive in histologic pattern and immunohistochemical profile. When interpreted within the context of staging, spindle cell and mixed spindle/lymphocytic thymomas presenting in stages I and II most likely behave in an indolent fashion.